Altamira Therapeutics
Company Details
Status: Public
Employees: 11-50
Location:
Hamilton, Bermuda
Type:
sample
Technology:
sample
sample
sample
sample
sample
sample
About: Altamira Therapeutics (former Auris Medical) is dedicated to developing therapeutics that address important unmet medical needs.
The Company is currently active in three areas:
• the development of RNA therapeutics for extrahepatic therapeutic targets (OligoPhore™ / SemaPhore™ platforms; preclinical),
• nasal sprays for protection against airborne viruses and allergens (Bentrio™; commercial) or the treatment of vertigo (AM-125; Phase 2)
• the development of therapeutics for intratympanic treatment of tinnitus or hearing loss (Keyzilen® and Sonsuvi®, Phase 3).
The Company was founded in 2003, under the name Auris Medical, and is headquartered in Hamilton, Bermuda with its main operations in Basel, Switzerland. The shares of Altamira Therapeutics Ltd. trade on the NASDAQ Capital Market under the symbol “CYTO.”
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Altamira Therapeutics | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.